PathoQuest to Participate in the Next-Generation CAR-TCR European Event

Accelerate to the Clinic Novel, New Generation Cell Therapies that are Safer, More Effective and Have Meaningful Impact in Diseases Beyond Oncology.

As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it’s more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next-generation developments and innovations to create the therapies of tomorrow.

That’s why PathoQuest is partnering with CAR-TCR Europe to the Next Generation CAR-TCR Summit, a platform focused on the 2.0, next-generation innovations in cell therapies.

Our team will be there among other innovators from large pharma, biotech, academia, and regulatory boards to hear insights into.